Effect of Nicotinamide Mononucleotide on Retinal Thickness of Older Patients With Diabetes Mellitus: A Placebo‐Controlled, Double‐Blind Study

烟酰胺单核苷酸 视网膜 医学 安慰剂 糖尿病性视网膜病变 糖尿病 眼科 视网膜病变 光学相干层析成像 视力 视野试验 视网膜 内科学 烟酰胺 不利影响 发病机制 烟酰胺 内分泌学 口服 眼病 烟酰胺腺嘌呤二核苷酸 视网膜色素上皮 随机对照试验
作者
Akihiko Shiraki,Chikako Hara,Hiroshi Akasaka,Hironori Nakagami,Ken Sugimoto,Yukiko Yasunobe,Tomohiro Minami,Taku Fujimoto,Koichi I. Yamamoto,Kento Asano,Masanobu Kanou,Kei Yamana,Shin‐ichiro Imai,Hiromi Rakugi,Kohji Nishida
出处
期刊:Geriatrics & Gerontology International [Wiley]
卷期号:26 (5): e70516-e70516 被引量:1
标识
DOI:10.1111/ggi.70516
摘要

OBJECTIVE: Nicotinamide mononucleotide (NMN) improves the pathogenesis of age-related changes and diseases by increasing intracellular nicotinamide adenine dinucleotide+. We aimed to evaluate retinal thickness changes after oral NMN administration according to the Early Treatment Diabetic Retinopathy Study (ETDRS) grid. METHODS: Before and 24 weeks after the study initiated, 240 × 240 mm macular cube scan optical coherence tomography images were obtained from male patients with type 2 diabetes aged ≥ 65 years with physical frailty; changes in the automatically measured mean retinal thickness within the 9 ETDRS grid regions were compared between groups. Participants were randomly assigned to receive 250 mg/day NMN or placebo orally for 24 weeks. Retinal thickness changes at 24 weeks were compared between groups. RESULTS: Each group included 14 eyes of 7 patients; 8 eyes had ocular disease. Best-corrected visual acuity did not change significantly between baseline and 24 weeks for both groups. In the temporal subretinal field of the outer circle, the retinal thickness change from baseline to 24 weeks differed significantly between the NMN and placebo groups (+1.14 ± 2.85 μm and -2.77 ± 3.30 μm, respectively; p = 0.006). Among patients without ocular disease, the NMN group demonstrated a trend toward suppressed reduction in retinal thickness in the temporal region (+0.75 ± 3.20 μm and -2.45 ± 3.33 μm in the NMN and placebo groups, respectively; p = 0.07). Systematic and ophthalmic adverse events were not observed in the NMN group. CONCLUSIONS: The oral NMN administration was safe both systemically and locally in the eyes. Based on the retinal thickness results, NMN may be efficacious in mitigating age-related alterations in the retina.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
华仔的应助被zero采纳,获得10
1秒前
李健的小迷弟的应助被cc采纳,获得10
1秒前
啊啊发布了新的文献求助80
1秒前
ding的应助被蓝色记忆采纳,获得10
1秒前
sunnymoon发布了新的文献求助10
1秒前
隶书发布了新的文献求助60
2秒前
阿金完成签到,获得积分20
2秒前
2秒前
2秒前
蓝天的应助被秃头的彬彬采纳,获得10
2秒前
BingYu发布了新的文献求助10
2秒前
龙仔的应助被华安采纳,获得10
3秒前
黑就嘿完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
自然黎云完成签到,获得积分20
4秒前
愉快惮的应助被caijiaqi采纳,获得10
4秒前
4秒前
所所的应助被caijiaqi采纳,获得10
4秒前
4秒前
小王同学完成签到,获得积分10
4秒前
4秒前
烂漫的涫完成签到,获得积分10
4秒前
义气的青枫完成签到,获得积分10
5秒前
拼搏的紫真完成签到,获得积分10
5秒前
慕青的应助被Liao采纳,获得10
5秒前
6秒前
ruby发布了新的文献求助10
6秒前
gly完成签到,获得积分10
6秒前
6秒前
WH发布了新的文献求助10
7秒前
zx598376321完成签到,获得积分0
7秒前
8秒前
旺旺小仙完成签到,获得积分10
8秒前
ty12390发布了新的文献求助10
8秒前
8秒前
科目三的应助被钱百万采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161554
求助须知:如何正确求助?哪些是违规求助? 9556174
关于积分的说明 21732775
捐赠科研通 7751537
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2472023